UNIVERSITY COLLEGE LONDON
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study
- Conditions
- Charcot-Marie-Tooth Disease, Type IACharcot-Marie-Tooth Disease Type 2ACharcot-Marie-Tooth Disease, Type IBCharcot-Marie-Tooth Disease, Type X
- First Posted Date
- 2018-06-08
- Last Posted Date
- 2018-10-04
- Lead Sponsor
- University College, London
- Target Recruit Count
- 130
- Registration Number
- NCT03550300
- Locations
- 🇬🇧
Queen Square Centre for Neuromuscular Diseases, London, United Kingdom
Responses to Appetite and Taste in the Brain Circuits That Control Eating Behaviour
Suspended
- Conditions
- Obesity
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- University College, London
- Target Recruit Count
- 75
- Registration Number
- NCT03547063
- Locations
- 🇬🇧
University College London Hospital, London, United Kingdom
Spinal Stimulation Sit-to-Stand Training After Spinal Cord Injury
Not Applicable
Terminated
- Conditions
- Spinal Cord Injuries
- Interventions
- Other: Spinal StimulationOther: Sit-to-stand Training
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- University College, London
- Target Recruit Count
- 9
- Registration Number
- NCT03536338
- Locations
- 🇬🇧
Royal National Orthopaedic Hospital, Stanmore, Middlesex, United Kingdom
Magnetic Resonance Imaging in Obesity
Completed
- Conditions
- Obesity
- Interventions
- Other: MRIOther: Written Consent
- First Posted Date
- 2018-05-17
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- University College, London
- Target Recruit Count
- 49
- Registration Number
- NCT03528187
- Locations
- 🇬🇧
University College London Hospital, London, United Kingdom
HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment
- Conditions
- Infectious DiseaseHepatitis C
- First Posted Date
- 2018-05-15
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- University College, London
- Target Recruit Count
- 164
- Registration Number
- NCT03524794
- Locations
- 🇬🇧
University College London, London, United Kingdom
MIAMI Safe Surgery for Multiple Breast Cancers
Not Applicable
Completed
- Conditions
- Breast Cancer, Unilateral
- Interventions
- Procedure: Therapeutic MammoplastyProcedure: Mastectomy
- First Posted Date
- 2018-05-02
- Last Posted Date
- 2021-05-18
- Lead Sponsor
- University College, London
- Target Recruit Count
- 4
- Registration Number
- NCT03514654
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, United Kingdom
🇬🇧Royal Hampshire Hospital, Winchester, United Kingdom
🇬🇧South Glasgow Hospitals - New Victoria Hospital / Gartnavel General Hospital, Glasgow, United Kingdom
Development of Photoacoustic Tomography
- Conditions
- Cardiovascular DiseasesCancer
- Interventions
- Other: Photoacoustic tomography
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- University College, London
- Target Recruit Count
- 27
- Registration Number
- NCT03501823
- Locations
- 🇬🇧
University College London Hospital, London, United Kingdom
Extended Follow up of the TARGIT-A Trial
- Conditions
- Breast Neoplasm Female
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- University College, London
- Target Recruit Count
- 714
- Registration Number
- NCT03501121
- Locations
- 🇬🇧
University College London, London, United Kingdom
🇬🇧Royal Hampshire County Hospital, Winchester, United Kingdom
Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections
- Conditions
- Chronic Viral Hepatitis BChronic Hepatitis CChronic HIV InfectionDiagnostic
- Interventions
- Diagnostic Test: blood draw
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- University College, London
- Target Recruit Count
- 100
- Registration Number
- NCT03495570
- Locations
- 🇬🇧
Mortimer Market centre, London, United Kingdom
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
Phase 2
Active, not recruiting
- Conditions
- Head and Neck CancerSquamous Cell Carcinoma
- Interventions
- First Posted Date
- 2018-04-11
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University College, London
- Target Recruit Count
- 130
- Registration Number
- NCT03494322
- Locations
- 🇬🇧
University College Hospital, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath